Plasma exosomes may mediate the development of lupus nephritis in patients with systemic lupus erythematosus
Lupus · 2024
DOI: 10.1177/09612033241298047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lupus, 2024. Verfasst von Jie Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China. Hauptthemen laut MEDLINE: Exosomes, Lupus Nephritis, MicroRNAs, Apoptosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, Graduate innovation fund, Science and Technology Office of Yunnan.
Abstract (Originalsprache)
Background
Lupus nephritis (LN) is the most serious complication of systemic lupus erythematosus (SLE), and plasma exosomes may serve as a bridge. MicroRNAs (miRNAs) are abundant in exosomes, so this study aimed to explore the role of exosome-derived miRNA in the development of LN.
Methods
The publicly available data containing plasma exosomal miRNAs in SLE patients and healthy controls were researched, and differential expression and functional enrichment analysis of exosomal miRNA was conducted. Then, plasma exosomes from SLE patients were extracted, and the accuracy of differential expression and functional enrichment analysis was preliminarily verified. PKH26 dye was used to label exosomes to detect whether exosomes can enter HK2 cells. Evaluation of plasma exosomes impact on cell viability was done by utilizing CCK-8 assay. Flow cytometry was used to measure cell apoptosis.
Results
Plasma exosomes were successfully extracted and identified. Through differential expression analysis of the pulbilic data and subsequent qPCR validation, we observed that miR-20b-5p is overexpressed in plasma exosomes of SLE patients, whereas miR-181a-2-3p is downregulated. Then functional enrichment analysis revealed that these differential miRNAs primarily regulate processes such as apoptosis, autophagy, and inflammation. Then, flow cytometry analysis conducted after co-incubation of plasma exosomes and peripheral blood mononuclear cells confirmed that exosomes can indeed regulate apoptosis. And plasma exosomes can successfully enter HK2 cells without affecting cell activity. In addition, plasma exosomes promote HK2 cell apoptosis and autophagy. Overexpression of miR-181a-2-3p could inhibit HK2 cells apoptosis and upregulate the expression of bcl2, and beclin1. At the same time, a trend towards increased apoptosis rates was observed in HK2 overexpressed miR-20b-5p, although the difference did not reach statistical significance. And miR-20b-5p can enhance the expression of caspase3 and becin1 while suppressing the expression of bcl2 and LC3β.
Conclusion
Our research indicates that the abundant presence of miR-20b-5p and the depletion of miR-181a-2-3p in plasma exosomes of SLE patients may mediate the promotion of apoptosis and autophagy in HK2 cells, thereby causing kidney damage and the development of LN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
ORCID-Profile: Xiaolan Li
Förderung
- the National Natural Science Foundation of China
- Graduate innovation fund
- Science and Technology Office of Yunnan
- Yunnan Basic Research Project
Zitieren
APA
Liu, J., Liu, Y., Xu, Y., Ye, J., Zhu, Y., & Li, X. (2024). Plasma exosomes may mediate the development of lupus nephritis in patients with systemic lupus erythematosus. Lupus. https://doi.org/10.1177/09612033241298047
Vancouver
Liu J, Liu Y, Xu Y, Ye J, Zhu Y, Li X. Plasma exosomes may mediate the development of lupus nephritis in patients with systemic lupus erythematosus. Lupus. 2024. doi:10.1177/09612033241298047
BibTeX
@article{Liu2024,
author = {Liu, Jie and Liu, Yuanju and Xu, Yinde and Ye, Jianjun and Zhu, Yun and Li, Xiaolan},
title = {Plasma exosomes may mediate the development of lupus nephritis in patients with systemic lupus erythematosus},
journal = {Lupus},
year = {2024},
doi = {10.1177/09612033241298047}
}
EUVIMED